AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of AL-38583 in the treatment
of the signs of inflammation associated with allergic conjunctivitis.